Contact us to discuss your target biology, ligase hypothesis, or molecular glue discovery strategy
Submit Inquiry* Please be kindly noted that our services and products are for research use only and are intended for organizations and companies rather than individual use.
BOC Sciences provides integrated molecular glue technology development services for pharmaceutical companies, biotechnology innovators, academic research teams, and discovery partners seeking practical solutions for induced proximity and targeted protein modulation. Our support spans target and ligase feasibility analysis, hit discovery strategy design, interaction mechanism validation, medicinal chemistry optimization, and developability evaluation. By addressing key bottlenecks such as uncertain E3 ligase compatibility, low hit-finding efficiency, weak or transient induced protein-protein interactions, and limited mechanistic clarity, we help clients build molecular glue programs with stronger scientific rationale and clearer advancement decisions.
To support early-stage decision-making, we assess target biology, tractability, interaction context, and ligase compatibility to determine whether a molecular glue mechanism is worth pursuing. This service helps reduce uncertainty and improve project prioritization at the outset.
Productive molecular glue activity depends on selecting the right biological context. We help clients evaluate ligase systems, substrate recruitment logic, and possible induced proximity routes to establish a more rational starting point for hit discovery.
Because molecular glue discovery is often limited by assay design and hit-finding efficiency, we establish screening workflows tailored to your target biology and mechanism hypothesis. These efforts help clients identify promising chemistry with better confidence and lower false-positive risk.
Understanding why a molecular glue works is critical for optimization. We support structure-based interpretation of target-ligand and protein-protein interactions to help identify interface determinants, induced contacts, and opportunities for improving selectivity and activity.
We establish validation workflows to determine whether observed activity is truly driven by molecular glue behavior rather than nonspecific effects. These studies help clients confirm induced interactions, biological relevance, and pathway-level consequences.
We support the transition from hit to optimized molecule through iterative chemistry and property assessment. By balancing biological performance with developability considerations, we help clients identify compounds with stronger overall research value.
Have You Encountered These Challenges in Molecular Glue Development?
Tell Us Your Challenge
Contact us to discuss your target biology, ligase hypothesis, or molecular glue discovery strategy
Submit InquiryMolecular glue development often requires a more exploratory yet more mechanism-aware workflow than conventional small-molecule programs. To help clients reduce uncertainty and improve project efficiency, we provide integrated solutions from early feasibility analysis to optimized candidate support.
We evaluate target biology, protein surface context, known ligand information, potential inducible interfaces, and relevant E3 ligase systems to determine whether a molecular glue strategy is technically and scientifically credible. This helps clients refine project direction and avoid blind discovery efforts.
We design tailored discovery workflows that combine focused library planning, virtual prioritization, phenotypic or mechanism-guided screening, and early hit triage. These strategies are intended to improve the chances of finding productive glue-like chemistry even when interactions are weak or transient.
After hit identification, we integrate medicinal chemistry, structural interpretation, and biological validation to improve activity, selectivity, and mechanistic confidence. This enables clients to progress from exploratory hits to molecules with stronger research and development value.
We evaluate solubility, stability, permeability trends, off-target risks, and assay translatability to help clients prioritize the most promising compounds. By combining mechanism and developability perspectives early, we support more reliable program advancement decisions.
Choose BOC Sciences to Advance Molecular Glue Discovery
BOC Sciences provides flexible, project-specific molecular glue development services designed around your target class, ligase biology, discovery stage, and research goals. With integrated support across biology, chemistry, and validation studies, we help reduce technical uncertainty and improve the path from concept to optimized molecule.
Academic teams often focus on target biology, induced proximity mechanisms, and proof-of-concept studies. We help these groups establish clearer molecular glue hypotheses, generate stronger validation data, and accelerate mechanistic research outputs.
Biotech companies need practical discovery strategies that can rapidly translate concepts into differentiated assets. Our integrated molecular glue support helps shorten exploratory cycles, improve hit confidence, and generate data packages that support internal decision-making and pipeline advancement.
For pharmaceutical organizations, molecular glues offer a valuable route to novel target classes and event-driven pharmacology. We provide systematic support for mechanism exploration, hit identification, optimization, and candidate prioritization across complex discovery workflows.
When internal infrastructure does not fully cover molecular glue biology, screening, or validation requirements, we offer modular support that helps CROs and technical platforms expand project coverage and respond more effectively to client needs.
Inquiry and Requirement Collection
Understand the client’s target background, project objectives, mechanism assumptions, timeline, and service expectations.
Feasibility Assessment and Discovery Strategy Planning
Evaluate target suitability, ligase options, interaction hypotheses, and the most appropriate hit discovery and validation path.
Proposal Design, Scope Definition, and Quotation
Define the research scope, technical modules, deliverables, and proposed workflow according to project needs.
Project Initiation and Background Data Transfer
Launch the project and collect relevant biological data, existing compounds, assay information, and research assumptions from the client.
Screening Design and Hit Discovery
Build tailored screening workflows, prioritize chemical matter, and identify early molecules with glue-like activity potential.
Mechanism Validation and Biological Evaluation
Confirm induced interactions, pathway relevance, and functional outcomes using mechanism-focused and activity-oriented studies.
Chemistry Optimization and Developability Review
Refine promising hits through iterative design and property evaluation to improve activity, selectivity, and research usability.
Molecule Delivery and Data Reporting
Deliver compounds, experimental datasets, and project conclusions to support subsequent internal research decisions.
Compared with bifunctional degraders, molecular glues often rely on smaller and structurally simpler molecules, which can be advantageous for compound optimization, physicochemical property control, and downstream discovery efficiency.
Molecular glue technology can induce or stabilize previously weak or transient interactions between a target protein and an E3 ligase, opening new possibilities beyond conventional occupancy-driven pharmacology.
For targets that lack clear binding pockets or are difficult to modulate through traditional inhibitor strategies, molecular glues may provide an alternative route to achieve selective functional regulation or degradation.
By leveraging context-dependent ternary interactions and unique ligase biology, molecular glue discovery offers opportunities to uncover differentiated mechanisms and create novel starting points for targeted protein modulation.

Project Background
A biotechnology client was interested in a transcription-associated protein with strong disease relevance but limited suitability for conventional inhibitor development. The client wanted to explore whether a molecular glue strategy could create a differentiated discovery route, but lacked a clear ligase hypothesis, screening workflow, and mechanism validation plan.
Our Support
We began with a target feasibility and interaction-context review to identify potential induced-proximity opportunities and prioritize the most relevant ligase hypotheses. Based on this analysis, we designed a focused screening workflow that combined virtual prioritization, a compact screening set, and mechanism-informed hit triage. After the initial campaign, we shortlisted 18 primary hits and progressed 6 compounds into confirmatory studies. Through iterative chemistry analysis, interaction modeling, and biological validation, we identified 2 lead-like molecules that reproducibly enhanced the target-associated interaction signature and showed clear functional activity in cellular assays. Compared with the original screening hits, the top compound series delivered stronger consistency, better selectivity trends, and a more actionable optimization direction for the client.
Client Testimonial
BOC Sciences helped us turn a highly exploratory concept into a much more structured molecular glue discovery program. Their team provided practical guidance on screening logic, hit validation, and optimization priorities, which significantly improved our project clarity.
Project Background
A pharmaceutical discovery team aimed to build a ligase-centered molecular glue platform around a protein degradation concept but faced uncertainty in substrate recruitment logic, hit-finding strategy, and early mechanism confirmation. The client needed an external partner to support both technical exploration and efficient project execution.
Our Support
We first mapped the client’s ligase system, target class assumptions, and intended biological outcome, then established a phased discovery plan covering hypothesis generation, screening design, and validation criteria. We screened multiple chemistry directions and evaluated their ability to promote productive interaction signatures using a mechanism-focused assay cascade. Across the project, we assessed more than 40 compounds and identified 5 validated active series for deeper review. By integrating structure-guided interpretation, analog prioritization, and functional testing, we narrowed the project to 1 most promising chemistry family with improved reproducibility, clearer mechanism evidence, and better developability trends than the earlier hits. This gave the client a stronger basis for internal expansion of the program.
Client Testimonial
From project design to hit refinement, BOC Sciences provided systematic and responsive support throughout our molecular glue discovery effort. Their ability to connect biology, chemistry, and mechanism evaluation helped us make faster and more confident decisions.
Mechanism-Oriented Discovery Support
We combine target biology, ligase logic, screening design, and interaction validation to support more credible molecular glue discovery.

Flexible, Customized Project Design
We tailor technical strategies and service modules to your target class, mechanism assumptions, and discovery stage.
Integrated Biology and Chemistry Expertise
Our team supports projects across feasibility assessment, hit discovery, validation, and optimization to improve continuity and efficiency.
Efficient Hit-to-Lead Progression
We help clients move from exploratory hits toward more actionable compounds through iterative analysis and prioritization.
Strong Interpretation and Decision Support
We provide clear data interpretation and practical optimization guidance to support project decisions at each stage.
Designed for Complex Discovery Questions
Our workflows are especially suited to projects where conventional screening and inhibitor approaches have not provided a sufficient path forward.
The core value of molecular glue technology development lies in its ability to induce or stabilize protein–protein interactions, creating new therapeutic opportunities for targets that are difficult to address with conventional small molecules. For drug development professionals, this means access to broader target space, novel mechanisms of action, and stronger differentiation potential in early discovery programs. Molecular glues have therefore become an important strategy for advancing targeted protein modulation and expanding the boundaries of small-molecule drug discovery.
Although both molecular glues and PROTACs can promote targeted protein degradation, they differ substantially in molecular design, screening logic, and optimization strategy. Molecular glues are usually smaller and structurally simpler, but their discovery depends more heavily on identifying compounds that can trigger productive protein–protein interactions. This makes mechanistic validation especially important. At BOC Sciences, we support clients with integrated services spanning hit discovery, interaction analysis, and lead optimization, helping improve the efficiency and confidence of molecular glue development programs.
One of the biggest challenges in molecular glue drug discovery is not simply finding an active compound, but proving that the compound works through the desired mechanism and can be developed into an optimizable series. Because molecular glues rely on induced ternary interactions, interface stability, and functional activity in biologically relevant systems, hit validation requires more than a single assay result. A successful program usually depends on combining screening, protein interaction studies, degradation analysis, and mechanistic investigation to turn early hits into well-understood development candidates.
Improving the success rate of molecular glue screening requires a mechanism-oriented discovery strategy rather than relying only on endpoint activity data. High-quality programs often integrate target assessment, customized assay design, hit validation, protein interaction profiling, and structure–activity relationship studies from the beginning. This helps identify false positives, weakly translatable hits, and compounds with unclear mechanisms at an early stage. BOC Sciences can support molecular glue discovery through flexible service workflows that connect screening, functional evaluation, and lead optimization, allowing clients to move forward with more robust data and stronger project confidence.
When choosing a molecular glue service partner, clients should focus on whether the team can provide true multidisciplinary support rather than isolated experimental tasks. A valuable partner should be able to understand target biology, establish fit-for-purpose screening models, validate protein interactions, and rapidly transition promising hits into an optimization cycle. Since molecular glue projects often involve complex mechanisms and long validation pathways, scientific integration and problem-solving capability are especially important. BOC Sciences provides tailored drug discovery support for molecular glue-related projects, helping clients advance programs more efficiently and with greater technical confidence.
Please contact us with any specific requirements and we will get back to you as soon as possible.